- Shanghai Nianxing Industrial Co., Ltd
- China
- Product Name: NSC-658497
- Price:
- Purity: 98.0%
- Stocking Period: 10 Day
- Contact: Tom
- DC Chemicals Limited
- China
- Product Name: NSC 658497
- Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
- Purity: 98.0%
- Stocking Period: 3 Day
- Contact: Tony Cao
- ShangHai DC Chemicals Co.,Ltd
- China
- Product Name: NSC 658497
- Price: ￥Inquiry/1g
- Purity: 98.9%
- Stocking Period: 1 Day
- Contact: Tony Lai
909197-38-2
909197-38-2 structure
- Name: NSC 658497
- Chemical Name: (Z)-3-(((Z)-5-(4-nitrobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)methylene)chroman-2,4-dione
- CAS Number: 909197-38-2
- Molecular Formula: C20H10N2O6S2
- Molecular Weight: 438.43300
- Catalog: Signaling Pathways GPCR/G Protein Ras
- Create Date: 2018-11-24 19:40:38
- Modify Date: 2024-01-10 00:43:48
-
NSC-658497 is an effective inhibitor of Ras-GEF, SOS1. NSC-658497 binds to SOS1, competitively suppresses SOS1-Ras interaction, and dose-dependently inhibits SOS1 GEF activity. NSC-658497 showed dose-dependent efficacy in inhibiting Ras, downstream signaling activities, and associated cell proliferation[1].
| Name | (Z)-3-(((Z)-5-(4-nitrobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)methylene)chroman-2,4-dione |
|---|---|
| Synonyms | nsc-658497 |
| Description | NSC-658497 is an effective inhibitor of Ras-GEF, SOS1. NSC-658497 binds to SOS1, competitively suppresses SOS1-Ras interaction, and dose-dependently inhibits SOS1 GEF activity. NSC-658497 showed dose-dependent efficacy in inhibiting Ras, downstream signaling activities, and associated cell proliferation[1]. |
|---|---|
| Related Catalog | |
| In Vitro | NSC-658497 (0-20 μM; 2 hours; NIH/3T3 cells) dose-dependently inhibits EGF (50 ng/mL)-stimulated Ras, but not EGFR activation[1]. Concomitant to Ras inhibition, NSC-658497 (0-100 μM; 2 hours; NIH/3T3 cells) dose-dependently inhibited the EGF activated, Ras downstream targets ERK1/2 and AKT[1]. Consistent with these results, NSC-658497 dose-dependently suppressed Ras signaling mediated by the overexpression of an active SOS1 mutant (W729L), originally identified in Noonan’s Syndrome, in human embryonic kidney cells[1]. NSC-658497 dose-dependently inhibits 50 nM SOS1-cat mediated GDP/GTP nucleotide exchange upon 2 μM H-Ras (aa. 1-166) in the BODIPYFL-GDP dissociation assay (IC50=15.4μM)[1]. NSC-658497 (0-60 μM; 3 days; PC-3 and DU-145 cells) inhibits proliferation of prostate cancer cells[1]. NSC-658497 (0-60 μM; 2 hours; PC-3 and DU-145 cells) dose-dependently inhibits Ras-GTP activity and the downstream p-ERK1/2 and p-Akt activities[1]. Cell Proliferation Assay[1] Cell Line: PC-3 and DU-145 cells Concentration: 0-60 μM Incubation Time: 3 days Result: Dose-dependently inhibited proliferation of PC-3 and DU-145 cells. Western Blot Analysis[1] Cell Line: PC-3 and DU-145 cells Concentration: 0-60 μM Incubation Time: 2 hours Result: Dose-dependently inhibited Ras-GTP activity and the downstream p-ERK1/2 and p-Akt activities. |
| References |
| Molecular Formula | C20H10N2O6S2 |
|---|---|
| Molecular Weight | 438.43300 |
| Exact Mass | 437.99800 |
| PSA | 166.89000 |
| LogP | 3.94290 |
| Hazard Codes | Xi |
|---|